课题基金 / 基金详情

INTRACELLULAR INFECTION BY INVASIVE GROUP A STREPTOCOCCI

INTRACELLULAR INFECTION BY INVASIVE GROUP A STREPTOCOCCI
侵袭性 A 型链球菌的细胞内感染
批准号:
2757762
负责人:
PAUL Patrick CLEARY
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-12-01 至 2002-11-30

项目摘要

项目成果

PAUL Patrick CLEARY的其他基金

相似基金

相关文献

中文摘要
翻译
包括败血症、中毒性休克和坏死性筋膜炎在内的严重A组链球菌病的重新出现已被充分记录。 尽管其他血清型与这些并发症相关,但流行病学数据认为,血清型M1 inv+亚克隆是20世纪90年代中毒性休克发病率增加的原因。 我们的实验室是第一个鉴定出M1克隆变体的实验室,这种变体最终传播到至少五大洲。 本项目的总体目标是了解上皮细胞的细胞内侵袭在人群中A组链球菌高毒力菌株的持续存在和传播中的作用。 许多研究将集中在M蛋白-细胞外基质蛋白层粘连蛋白和纤连蛋白与上皮细胞之间的分子相互作用。 实验将确定M1蛋白和其他噬菌体和染色体编码蛋白在人类细胞高频率入侵中的作用。侵袭素激动剂功能将使用乳胶珠和扫描电子显微镜与其他链球菌因子分开分析。 最后,将使用扁桃体器官培养物验证高频侵袭的体外要求。 这些研究可能为青霉素不能根除复发性感染儿童口腔粘膜中的链球菌提供了一种解释。
英文摘要
The resurgence of serious group A streptococcal disease which includes sepsis, toxic shock and necrotizing fasciitis has been thoroughly documented. Although other serotypes are associated with these complications, epidemiological data argue that the serotype M1 inv+ subclone was responsible for the increased incidence of toxic shock in the 1990s. Our laboratory was the first to identify the M1 clonal variant that ultimately spread to at least five continents. The overall goal of this project is to understand the role of intracellular invasion of epithelial cells in the persistence and dissemination of highly virulent strains of group A streptococci in human populations. Much of the study will focus on the molecular interactions between M protein-extracellular matrix proteins laminin and fibronectin and the epithelial cell. Experiments will define the role of M1 protein and other bacteriophage and chromosomally encoded proteins in high frequency invasion of human cells. Invasin-agonist functions will be analyzed separate from other streptococcal factors using latex beads and scanning electron microscopy. Finally, in vitro requirements for high frequency invasion will be validated using tonsil organ cultures. These studies may provide an explanation for the failure of penicillin to eradicate streptococci from the oral mucosa of children with recurrent infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell immune response to group A streptococci in NALT
  • 批准号:
    6867089
  • 项目类别:
  • 资助金额:
    $29.41万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    7154787
  • 项目类别:
  • 资助金额:
    $28.35万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    6989110
  • 项目类别:
  • 资助金额:
    $29.2万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    7323232
  • 项目类别:
  • 资助金额:
    $27.31万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
国内基金
海外基金
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
  • 批准号:
    31770069
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    孙宇辉
  • 依托单位: